Author

Ian Dryden

Mayo Clinic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Aleeshba N. BasiliD· 1 shared Alfredo Quiñones‐HinojosaiD· 1 shared Asha Nair· 1 shared Brianna Tapia-Dierking· 1 shared Cristina Gomez-PalmeroiD· 1 shared Graciela Abril Reynaga-MaciasiD· 1 shared Haidong DongiD· 1 shared Hong QiniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aleeshba N. BasilORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Intracranial Targeting of Cholesterol Processing Reveals a Therapeutic Vulnerability that Reprograms Glioblastoma and Promotes Antitumor Immunity

María José Ulloa-Navas, Rachel Whitehead, Vanessa K. Jones, Loizos Michaelides, Mieu Brooks, Aleeshba N. Basil, Raquel Morales‐Gallel, Cristina Gomez-Palmero, Graciela Abril Reynaga-Macias, Jesus Emiliano Sanchez-Garavito, Brianna Tapia-Dierking, Asha Nair, Juan Pablo Navarro Garcia de Llano, Paula V. Schiapparelli, Ian Dryden, , Alfredo Quiñones‐Hinojosa

This study identifies cholesterol dependency as a therapeutic target in glioblastoma, showing that combined treatment with clemastine and bexarotene induces metabolic collapse and enhances antitumor immunity.

bioRxiv · Aug 19, 2026 · PreprintCancer Biology